Merck selects SourceFuse to develop the first OTT Platform to digitize Global CME Events

[Jacksonville, Florida] Oct 25, 2020

Online CME, healthcare Professional, CME

SourceFuse announced today that Merck selected FlixMD – it’s OTT Platform to digitize global CME events by modernizing medical learning for HCPs. Merck will host their medical education videos on FlixMD which will be accessible to millions of HCP’s worldwide. With FlixMD’s world-class engineering, personalized content recommendations, and state of the art product experience, Merck will stay ahead of the curve and continue empowering the HCP community. 

“We are modernizing the way healthcare professionals embrace continuing medical education to accelerate the next generation of healthcare innovation,” said Dr. Rajiv Rana, Head of Medical Affairs, Asia Pacific at Merck Group. “FlixMD aligns with Merck’s vision to deliver innovative health solutions with science at the heart of everything and be digital future-ready for a more impactful tomorrow.” 

Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world. With FlixMD, Merck can bring together the recent discoveries in Healthcare and Life Sciences in the form of curated & medico regulated video content and scale globally to reach a wide audience of HCPs.

About FlixMD:

FlixMD is an On-Demand Video streaming platform dedicated to HCPs that makes it easy for doctors, physicians, healthcare SMEs to browse content based on relevant areas of therapies. Technologically powered by AWS, it is committed to modernizing remote health education dedicated to HCPs and is invested heavily to create a digital alternate for CMEs. 

From real-time personalized playlist suggestions & language translation to dynamic video analytics and content delivery network integration for optimized content caching, FlixMD exhibits the look and feel and packs the power of well-known OTT platforms. 

For the HCP’s ease of use, seamless user experience, and on-demand access to videos, it comes with an international subscription-based model and device-independent video streaming feature. And with FlixMD’s infra on AWS, it can enable multiple leading pharmaceuticals, hospitals, and more medical organizations to potentially host unlimited videos and reinvent the way HCPs learn about new and developing areas of their field. 

As per SourceFuse’s CEO, Gautam Ghai – “We think of FlixMD as the Netflix for doctor and healthcare SME community – easy & personalized user experience, dedicated for medical education & knowledge. We understand the ever-changing medical landscape and the need to showcase only the most evolved and up-to-date content. At the same time, it’s crucial for the videos to have authenticity and legitimate content for the healthcare community which not only expands their knowledge but also does that on-the-go. Hence, video upload rights will be limited with our partnered Healthcare Life Sciences companies keeping Medico-legal compliance at utmost priority. We could not have done this without Merck and a very special thanks to Dr. Rajiv Rana for the collaborative approach and being the early adopter and a sponsor to FlixMD.”

About Merck: 

For more than 125 years, Merck Group has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of their mission to save and improve lives. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions.

Merck firmly believes that corporate responsibility is about health, social, environmental, and economic impact on people and communities around the world. They demonstrate their commitment to patients and population health by increasing access to health care through far-reaching policies, programs, and partnerships. Recently in 2019, their research and development investment amounted to a sum total of $9.9 B. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease, and infectious diseases including HIV and Ebola. 

About SourceFuse:

SourceFuse Inc. is transforming the way today’s most successful companies develop breakthrough roadmaps leveraging cloud-based technologies, with a niche focus on Healthcare Life Sciences. A leading AWS Advanced Consulting Partner, SourceFuse has delivered over 600 AWS implementations that boost efficiency, ensure compliance, deliver actionable insights, and lower the total cost of ownership.

With 14 years of deep expertise, commitment to digital innovation, service excellence, and customer success, we enable enterprises through application modernization and windows migration services of legacy workloads. Headquartered in the United States, with offices in the UK, Australia, and India. For more updates, follow SourceFuse on LinkedIn and Twitter.